$ZUO
ZUORA INC Stock $zuo

$zuo Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000142377423000044 Filed on April 03, 2023

Income Statement

Concept	2023 Q1	2023	2022
Revenue	$103.0M	$396.1M	$346.7M
YoY Change	13.62%	14.23%	13.53%
Cost Of Revenue	$38.07M	$153.2M	$140.1M
YoY Change	6.63%	9.37%	7.14%
Gross Profit	$64.98M	$242.9M	$206.6M
YoY Change	18.15%	17.53%	18.31%
Gross Profit Margin	63.06%	61.31%	59.59%
Selling, General & Admin	$63.74M	$251.7M	$219.6M
YoY Change	16.45%	14.65%	27.88%
% of Gross Profit	98.1%	103.66%	106.27%
Research & Development	$24.93M	$102.6M	$83.22M
YoY Change	15.11%	23.25%	8.37%
% of Gross Profit	38.36%	42.23%	40.27%
Depreciation & Amortization	$5.013M	$18.74M	$11.43M
YoY Change	21.73%	63.94%	8.13%
% of Gross Profit	7.72%	7.72%	5.53%
Operating Expenses	$88.67M	$354.3M	$302.8M
YoY Change	16.07%	17.01%	21.85%
Operating Profit	-$23.69M	-$111.5M	-$96.18M
YoY Change	10.71%	15.89%	30.21%
Interest Expense	$1.402M	-$9.147M	-$1.822M
YoY Change	-277.92%	402.03%	-170.08%
% of Operating Profit
Other Income/Expense, Net	-$134.0K	$9.214M
YoY Change
Pretax Income	-$22.42M	-$111.4M	-$98.00M
YoY Change	-35.9%	13.66%	37.44%
Income Tax	$9.437M	$10.58M	$1.427M
% Of Pretax Income
Net Earnings	-$31.86M	-$122.0M	-$99.43M
YoY Change	-9.45%	22.68%	35.87%
Net Earnings / Revenue	-30.92%	-30.79%	-28.67%
Basic Earnings Per Share		-$1.51	-$0.80
Diluted Earnings Per Share	-$0.24	-$0.93	-$0.80
COMMON SHARES
Basic Shares Outstanding		131.4M shares	124.2M shares
Diluted Shares Outstanding		131.4M shares	124.2M shares

Balance Sheet

Concept	2023 Q1	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$386.2M	$386.2M	$215.4M
YoY Change	79.32%	79.32%	15.43%
Cash & Equivalents	$203.2M	$203.2M	$113.5M
Short-Term Investments	$183.0M	$183.0M	$101.9M
Other Short-Term Assets	$40.57M	$40.57M	$28.12M
YoY Change	44.24%	44.24%	7.75%
Inventory
Prepaid Expenses
Receivables	$91.74M	$91.74M	$83.55M
Other Receivables	$0.00	$0.00	$1.270M
Total Short-Term Assets	$518.6M	$518.6M	$328.3M
YoY Change	57.93%	57.93%	11.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$49.93M	$49.93M	$60.32M
YoY Change	80.4%	-17.23%	-25.07%
Goodwill	$53.99M
YoY Change	206.21%
Intangibles	$13.20M
YoY Change	282.42%
Long-Term Investments
YoY Change
Other Assets	$32.93M	$32.93M	$31.51M
YoY Change	587.84%	4.48%	22.15%
Total Long-Term Assets	$150.0M	$150.0M	$112.9M
YoY Change	32.88%	32.88%	-11.65%
TOTAL ASSETS
Total Short-Term Assets	$518.6M	$518.6M	$328.3M
Total Long-Term Assets	$150.0M	$150.0M	$112.9M
Total Assets	$668.6M	$668.6M	$441.3M
YoY Change	51.52%	51.52%	4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.073M	$1.073M	$6.785M
YoY Change	-84.19%	-84.19%	208.41%
Accrued Expenses	$67.40M	$67.40M	$55.69M
YoY Change	21.03%	21.03%	12.96%
Deferred Revenue	$167.1M
YoY Change	9.43%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$1.660M
YoY Change	-100.0%	-100.0%	-62.27%
Total Short-Term Liabilities	$235.6M	$235.6M	$219.3M
YoY Change	7.44%	7.44%	16.65%
LONG-TERM LIABILITIES
Long-Term Debt	$210.4M	$210.4M	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$45.70M	$45.70M	$48.11M
YoY Change	2586.6%	-5.0%	-17.06%
Total Long-Term Liabilities	$256.1M	$256.1M	$48.11M
YoY Change	14955.97%	432.38%	-19.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$235.6M	$235.6M	$219.3M
Total Long-Term Liabilities	$256.1M	$256.1M	$48.11M
Total Liabilities	$495.4M	$495.4M	$270.6M
YoY Change	83.06%	83.06%	8.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$761.4M
YoY Change	35.14%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$173.2M	$173.2M	$170.6M
YoY Change
Total Liabilities & Shareholders Equity	$668.6M	$668.6M	$441.3M
YoY Change	51.52%	51.52%	4.69%

Cashflow Statement

Concept	2023 Q1	2023	2022
OPERATING ACTIVITIES
Net Income	-$31.86M	-$122.0M	-$99.43M
YoY Change	-9.45%	22.68%	35.87%
Depreciation, Depletion And Amortization	$5.013M	$18.74M	$11.43M
YoY Change	21.73%	63.94%	8.13%
Cash From Operating Activities	-$17.97M	-$20.64M	$18.69M
YoY Change	-273.31%	-210.48%	65.57%
INVESTING ACTIVITIES
Capital Expenditures	$2.163M	$10.63M	$8.776M
YoY Change	-179.17%	21.17%	-33.23%
Acquisitions		$41.00M	$0.00
YoY Change
Other Investing Activities	$37.01M	-$120.4M	-$9.974M
YoY Change	-338.41%	1107.54%	-138.33%
Cash From Investing Activities	$34.85M	-$131.1M	-$20.10M
YoY Change	-290.89%	552.14%	-256.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$2.908M	$9.490M
YoY Change
Debt Paid & Issued, Net		$1.480M	$4.444M
YoY Change		-66.7%	0.09%
Cash From Financing Activities	2.908M	241.9M	$21.48M
YoY Change	-43.19%	1026.06%	43.4%
NET CHANGE
Cash From Operating Activities	-17.97M	-20.64M	$18.69M
Cash From Investing Activities	34.85M	-131.1M	-$20.10M
Cash From Financing Activities	2.908M	241.9M	$21.48M
Net Change In Cash	19.79M	90.19M	$19.40M
YoY Change	-814.22%	364.98%	-51.31%
FREE CASH FLOW
Cash From Operating Activities	-$17.97M	-$20.64M	$18.69M
Capital Expenditures	$2.163M	$10.63M	$8.776M
Free Cash Flow	-$20.13M	-$31.28M	$9.910M
YoY Change	-253.67%	-415.62%	-633.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001423774
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	1000000000	usd
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Santa Clara, California
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	203239000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	183006000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4001000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	91740000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	16282000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24285000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	518552000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27159000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22768000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13201000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	28250000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	53991000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4677000	usd
CY2023Q1	us-gaap	Assets Assets	668598000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1073000	usd
CY2023Q1	zuo	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	103678000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	30483000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1660000	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	152740000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11462000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	219297000	usd
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	771000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45633000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3243000	usd
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1701000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	270645000	usd
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	734149000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-108000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-563447000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	170607000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441252000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305420000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	130770000	usd
CY2021	us-gaap	Gross Profit GrossProfit	174650000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	76795000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	116914000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54803000	usd
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	248512000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-73862000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-9214000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Interest Expense InterestExpense	334000	usd
CY2023	zuo	Interest Income And Other Income Expense Net InterestIncomeAndOtherIncomeExpenseNet	5986000	usd
CY2022	zuo	Interest Income And Other Income Expense Net InterestIncomeAndOtherIncomeExpenseNet	-1670000	usd
CY2021	zuo	Interest Income And Other Income Expense Net InterestIncomeAndOtherIncomeExpenseNet	2895000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71301000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1873000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-73174000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	696000	usd
CY2021	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-88000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-72566000	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.51
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124206000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124206000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117598000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117598000	shares
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	164659000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11784000	usd
CY2021	zuo	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Lapse Of Restriction On Early Exercise AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsLapseOfRestrictionOnEarlyExercise	116000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7637000	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	59283000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	608000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-73174000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	171913000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18499000	usd
CY2022	zuo	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Lapse Of Restriction On Early Exercise AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsLapseOfRestrictionOnEarlyExercise	26000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7428000	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72070000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-904000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99425000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	170607000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2471000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	96401000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	18442000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-811000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-197970000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	97160000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-197970000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99425000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-73174000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18738000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16760000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15308000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	96401000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	72070000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	59283000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2245000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2919000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3686000	usd
CY2023	us-gaap	Noncash Contribution Expense NoncashContributionExpense	1000000	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	1000000	usd
CY2021	us-gaap	Noncash Contribution Expense NoncashContributionExpense	1000000	usd
CY2023	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	19291000	usd
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	16330000	usd
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	12401000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	7363000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	9717000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8265000	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4537000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12783000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-380000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-391000	usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	802000	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	73000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11081000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6322000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13671000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7379000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1179000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-895000	usd
CY2023	zuo	Increase Decrease In Capitalized Contract Cost IncreaseDecreaseInCapitalizedContractCost	22802000	usd
CY2022	zuo	Increase Decrease In Capitalized Contract Cost IncreaseDecreaseInCapitalizedContractCost	24127000	usd
CY2021	zuo	Increase Decrease In Capitalized Contract Cost IncreaseDecreaseInCapitalizedContractCost	17842000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-6084000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4457000	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	88353000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	7065000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	24281000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	16812000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13131000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-13969000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8974000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20644000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18686000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11286000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10634000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8776000	usd
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
CY2022	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	344000	usd
CY2021	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	988000	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1349000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	234246000	usd
CY2022	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	109510000	usd
CY2023	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2511000	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	154806000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	99192000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	119880000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	41000000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-131074000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20099000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12872000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	233901000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2471000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18499000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11784000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	7019000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	7428000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	7637000	usd
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1480000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4444000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	4440000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	241911000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21483000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14981000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-461000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-673000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	696000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	89732000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19397000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	39835000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113507000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94110000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54275000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203239000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113507000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94110000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	7608000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	94000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	262000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1445000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1395000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1159000	usd
CY2023	zuo	Lapse In Restrictions On Early Exercised Common Stock Options LapseInRestrictionsOnEarlyExercisedCommonStockOptions	0	usd
CY2022	zuo	Lapse In Restrictions On Early Exercised Common Stock Options LapseInRestrictionsOnEarlyExercisedCommonStockOptions	26000	usd
CY2021	zuo	Lapse In Restrictions On Early Exercised Common Stock Options LapseInRestrictionsOnEarlyExercisedCommonStockOptions	116000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	164000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	70000	usd
CY2023	zuo	Acquired Finite Lived Intangible Assets Consideration Retained For Indemnification Obligations AcquiredFiniteLivedIntangibleAssetsConsiderationRetainedForIndemnificationObligations	0	usd
CY2022	zuo	Acquired Finite Lived Intangible Assets Consideration Retained For Indemnification Obligations AcquiredFiniteLivedIntangibleAssetsConsiderationRetainedForIndemnificationObligations	225000	usd
CY2021	zuo	Acquired Finite Lived Intangible Assets Consideration Retained For Indemnification Obligations AcquiredFiniteLivedIntangibleAssetsConsiderationRetainedForIndemnificationObligations	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities at the date of the consolidated financial statements, as well as reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates. </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our most significant estimates and assumptions are related to revenue recognition with respect to the determination of the relative standalone selling prices for our services; the expected period of benefit over which deferred commissions are amortized; valuation of stock-based awards, our convertible senior notes and warrants; estimates of allowance for credit losses; estimates of the fair value of goodwill and long-lived assets when evaluating for impairments and for assets acquired from acquisitions; useful lives of intangibles and other long-lived assets; and the valuation of deferred income tax assets and contingencies. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Accordingly, actual results may differ materially from these estimates under different assumptions or conditions.</span></div>
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization Period CapitalizedContractCostAmortizationPeriod	P5Y
CY2023Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	1300000	usd
CY2022Q1	us-gaap	Contract With Customer Asset Gross Current ContractWithCustomerAssetGrossCurrent	1300000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentrations of Credit Risk and Significant Clients and SuppliersOur financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments and accounts receivable. We deposit our cash and short-term investments primarily with one financial institution and, accordingly, such deposits regularly exceed federally insured limits.
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3188000	usd
CY2023	zuo	Provision For Doubtful Accounts Charged To Revenue ProvisionForDoubtfulAccountsChargedToRevenue	2245000	usd
CY2022	zuo	Provision For Doubtful Accounts Charged To Revenue ProvisionForDoubtfulAccountsChargedToRevenue	2919000	usd
CY2023	zuo	Provision For Doubtful Accounts Charged To Deferred Revenue ProvisionForDoubtfulAccountsChargedToDeferredRevenue	1818000	usd
CY2022	zuo	Provision For Doubtful Accounts Charged To Deferred Revenue ProvisionForDoubtfulAccountsChargedToDeferredRevenue	1801000	usd
CY2023	zuo	Allowance For Doubtful Accounts Receivable Write Offs To Revenue AllowanceForDoubtfulAccountsReceivableWriteOffsToRevenue	2201000	usd
CY2022	zuo	Allowance For Doubtful Accounts Receivable Write Offs To Revenue AllowanceForDoubtfulAccountsReceivableWriteOffsToRevenue	3423000	usd
CY2023	zuo	Allowance For Doubtful Accounts Receivable Write Offs To Deferred Revenue AllowanceForDoubtfulAccountsReceivableWriteOffsToDeferredRevenue	1049000	usd
CY2022	zuo	Allowance For Doubtful Accounts Receivable Write Offs To Deferred Revenue AllowanceForDoubtfulAccountsReceivableWriteOffsToDeferredRevenue	2631000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4001000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3188000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12800000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	zuo	Employee Stock Purchase Plan Offering Period EmployeeStockPurchasePlanOfferingPeriod	P2Y
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	100000	usd
CY2023	us-gaap	Depreciation Depreciation	9668000	usd
CY2022	us-gaap	Depreciation Depreciation	11430000	usd
CY2021	us-gaap	Depreciation Depreciation	10571000	usd
CY2023	zuo	Number Of Sublease NumberOfSublease	1	sublease
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6600000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	183582000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	576000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	183006000	usd
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	102108000	usd
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	226000	usd
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	101882000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1480000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	10521000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	962000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1526000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12800000	usd
CY2023Q1	zuo	Prepaid Software Subscriptions Current PrepaidSoftwareSubscriptionsCurrent	7533000	usd
CY2022Q1	zuo	Prepaid Software Subscriptions Current PrepaidSoftwareSubscriptionsCurrent	6854000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	3860000	usd
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	1270000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	3225000	usd
CY2022Q1	us-gaap	Prepaid Insurance PrepaidInsurance	3220000	usd
CY2023Q1	us-gaap	Loss Contingency Receivable LossContingencyReceivable	2000000	usd
CY2022Q1	us-gaap	Loss Contingency Receivable LossContingencyReceivable	0	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	1168000	usd
CY2022Q1	us-gaap	Deposits Assets DepositsAssets	250000	usd
CY2023Q1	zuo	Prepaid Hosting Costs PrepaidHostingCosts	871000	usd
CY2022Q1	zuo	Prepaid Hosting Costs PrepaidHostingCosts	767000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	4303000	usd
CY2022Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1953000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24285000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15603000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63605000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	61942000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36446000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34266000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27159000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27676000	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1100000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	26467000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	13266000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13201000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	14467000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11015000	usd
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3452000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2251000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2050000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1692000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2953000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2509000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1874000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1561000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1561000	usd
CY2023Q1	zuo	Finite Lived Intangible Asset Expected Amortization After Year Five FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFive	2743000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	13201000	usd
CY2022Q1	us-gaap	Goodwill Goodwill	17632000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	35009000	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1350000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	53991000	usd
CY2022	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	75000000	usd
CY2022Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	usd
CY2023Q1	zuo	Accrued Contingent Consideration AccruedContingentConsideration	4420000	usd
CY2022Q1	zuo	Accrued Contingent Consideration AccruedContingentConsideration	0	usd
CY2023Q1	zuo	Accrued Hosting And License Fees Current AccruedHostingAndLicenseFeesCurrent	4374000	usd
CY2022Q1	zuo	Accrued Hosting And License Fees Current AccruedHostingAndLicenseFeesCurrent	3865000	usd
CY2023Q1	zuo	Accrued Goods And Services Taxes Current AccruedGoodsAndServicesTaxesCurrent	4088000	usd
CY2022Q1	zuo	Accrued Goods And Services Taxes Current AccruedGoodsAndServicesTaxesCurrent	2422000	usd
CY2023Q1	zuo	Accrued Outside Services And Consulting Current AccruedOutsideServicesAndConsultingCurrent	3507000	usd
CY2022Q1	zuo	Accrued Outside Services And Consulting Current AccruedOutsideServicesAndConsultingCurrent	3712000	usd
CY2023Q1	zuo	Warrant Liability Value WarrantLiabilityValue	2829000	usd
CY2022Q1	zuo	Warrant Liability Value WarrantLiabilityValue	0	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	850000	usd
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	3000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	8610000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4223000	usd
CY2023Q1	zuo	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	103678000	usd
CY2022Q1	zuo	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	14225000	usd
CY2023	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	8100000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	61000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	147036000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	126245000	usd
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	107091000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	500300000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.59
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	396087000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	346738000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	305420000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22768000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32643000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9240000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11462000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	37924000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	45633000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	47164000	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	57095000	usd
CY2023	us-gaap	Lease Cost LeaseCost	9933000	usd
CY2022	us-gaap	Lease Cost LeaseCost	12681000	usd
CY2021	us-gaap	Lease Cost LeaseCost	11933000	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	483000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	402000	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	193000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	98000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11288000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6874000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6493000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6705000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6800000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	17412000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	55572000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	8408000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	47164000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	189000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	163000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	46000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	10332000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.046
CY2023	zuo	Lessee Operating Lease Cash Paid For Operating Leases LesseeOperatingLeaseCashPaidForOperatingLeases	12802000	usd
CY2022	zuo	Lessee Operating Lease Cash Paid For Operating Leases LesseeOperatingLeaseCashPaidForOperatingLeases	13701000	usd
CY2021	zuo	Lessee Operating Lease Cash Paid For Operating Leases LesseeOperatingLeaseCashPaidForOperatingLeases	9693000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	12802000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13701000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	9693000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	799000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5040000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1064000	usd
CY2023Q1	zuo	Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount	3400000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Term Of Contract1 LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1	P36M
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4500000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12800000	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3300000	usd
CY2023	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1100000	usd
CY2023	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	100000	usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	9800000	usd
CY2022	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	2200000	usd
CY2022	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	800000	usd
CY2023Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	75000000	usd
CY2023Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1000000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-193031000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-101626000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-77140000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5643000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3628000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	5839000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-187388000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-97998000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-71301000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	799000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	465000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	347000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10582000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1427000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1873000	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-39351000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-20580000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14973000	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5312000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3466000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2072000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	450000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	772000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	718000	usd
CY2023	zuo	Effective Income Tax Rate Reconciliation Warrant Adjustment Amount EffectiveIncomeTaxRateReconciliationWarrantAdjustmentAmount	-1935000	usd
CY2022	zuo	Effective Income Tax Rate Reconciliation Warrant Adjustment Amount EffectiveIncomeTaxRateReconciliationWarrantAdjustmentAmount	0	usd
CY2021	zuo	Effective Income Tax Rate Reconciliation Warrant Adjustment Amount EffectiveIncomeTaxRateReconciliationWarrantAdjustmentAmount	0	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	6144000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	11263000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	1325000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	9230000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	502000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	600000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	7772000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-3427000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	1250000	usd
CY2023	zuo	Effective Income Tax Reconciliation Intercompany Transactions Amount EffectiveIncomeTaxReconciliationIntercompanyTransactionsAmount	-7204000	usd
CY2022	zuo	Effective Income Tax Reconciliation Intercompany Transactions Amount EffectiveIncomeTaxReconciliationIntercompanyTransactionsAmount	0	usd
CY2021	zuo	Effective Income Tax Reconciliation Intercompany Transactions Amount EffectiveIncomeTaxReconciliationIntercompanyTransactionsAmount	0	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	312000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1174000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	2435000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	52764000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	40063000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	15240000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10582000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1427000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1873000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	139298000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	133994000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	27256000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	21112000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	34884000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	14220000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3684000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	0	usd
CY2023Q1	zuo	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	1949000	usd
CY2022Q1	zuo	Deferred Tax Assets Depreciation And Amortization DeferredTaxAssetsDepreciationAndAmortization	2771000	usd
CY2023Q1	zuo	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	11314000	usd
CY2022Q1	zuo	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	13894000	usd
CY2023Q1	zuo	Deferred Tax Asset Research And Development Expense Capitalization DeferredTaxAssetResearchAndDevelopmentExpenseCapitalization	21040000	usd
CY2022Q1	zuo	Deferred Tax Asset Research And Development Expense Capitalization DeferredTaxAssetResearchAndDevelopmentExpenseCapitalization	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	239425000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	185991000	usd
CY2023Q1	zuo	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	11938000	usd
CY2022Q1	zuo	Deferred Tax Liabilities Deferred Commissions DeferredTaxLiabilitiesDeferredCommissions	10949000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	3253000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	5368000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	8001000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17306000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	22203000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	224648000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	166212000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2529000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2424000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	58400000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	40100000	usd
CY2020Q4	zuo	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	3600000	usd
CY2021Q4	zuo	Social Security Tax Employer Deferral Payment Cares Act SocialSecurityTaxEmployerDeferralPaymentCARESAct	1600000	usd
CY2022Q4	zuo	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	2000000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18400000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10200000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7000000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10228000	usd
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9385000	usd
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8070000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1135000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	124000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	2895000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	5000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	8247000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2603000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1320000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	18351000	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10228000	usd
CY2023	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	usd
CY2022	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	100000	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	101317	shares
CY2022	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	61012	shares
CY2023	us-gaap	Noncash Contribution Expense NoncashContributionExpense	1000000	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	1000000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-461000	usd
CY2023	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-350000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8560000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.22
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	67259000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	20000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.52
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	477000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.12
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	342000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	13.62
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7761000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.28
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14505000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3198000	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	3.38
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	14505000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7660000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.22
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	14505000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.54
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	6.54
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.69
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2600000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	32179000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	22677000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	96401000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	72070000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	59283000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-197970000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99425000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-73174000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131441000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	131441000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124206000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124206000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	117598000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	117598000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.51
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.51
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.80
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.80
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43486000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20875000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20229000	shares
CY2023Q1	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	75000000	usd

Files In Submission

Name	View Source	Status
0001423774-23-000044-index-headers.html	Edgar Link	pending
0001423774-23-000044-index.html	Edgar Link	pending
0001423774-23-000044.txt	Edgar Link	pending
0001423774-23-000044-xbrl.zip	Edgar Link	pending
a20230131ex211-q4form10xkx.htm	Edgar Link	pending
a20230131ex231.htm	Edgar Link	pending
a20230131ex311.htm	Edgar Link	pending
a20230131ex312.htm	Edgar Link	pending
a20230131ex321.htm	Edgar Link	pending
a20230131ex322.htm	Edgar Link	pending
a20230131ex42-q4form10xkxd.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
offerletterdatedjanuary920.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zuo-20230131.htm	Edgar Link	pending
zuo-20230131.xsd	Edgar Link	pending
zuo-20230131_g1.jpg	Edgar Link	pending
zuo-20230131_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
zuo-20230131_def.xml	Edgar Link	unprocessable
zuo-20230131_lab.xml	Edgar Link	unprocessable
zuo-20230131_pre.xml	Edgar Link	unprocessable
zuo-20230131_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZUO
ZUORA INC Stock $zuo

2023 Q1 Form 10-K Financial Statement

#000142377423000044 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZUO ZUORA INC Stock $zuo

2023 Q1 Form 10-K Financial Statement

#000142377423000044 Filed on April 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZUO
ZUORA INC Stock $zuo